Biography of Laura Sepp-Lorenzino
Last update: February 14, 2024Career
Laura was Vice President, Head Nucleic Acid Therapies, External Innovation at Vertex Pharmaceuticals, and Vice President, Entrepreneur in Residence at Alnylam Pharmaceuticals.
Laura Sepp-Lorenzino is currently- Executive Vice President and Chief Scientific Officer at Intellia Therapeutics - View - Intellia Therapeutics org chart
- Director at Taysha Gene Therapies - View - Taysha Gene Therapies org chart
Create your alert
to follow the career of Laura Sepp-Lorenzino.
Education
Laura Sepp-Lorenzino has a PhD in Biochemistry from New York University.
They have also studied at New York University :
Find more alumni from New York University
More about Laura Sepp-Lorenzino
Selected links
Do you need to know more about Laura Sepp-Lorenzino? More results.
Participate
Social media
- Laura Sepp-Lorenzino on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Laura Sepp-Lorenzino
The colleagues of Laura Sepp-Lorenzino
Company Colleagues
- At Intellia Therapeutics, Laura Sepp-Lorenzino has 20 colleagues including John Leonard (CEO & Director), Bill Chase (Director)…
- At Taysha Gene Therapies, Laura Sepp-Lorenzino has 11 colleagues including Sean Nolan (CEO & Chairman), Phillip Donenberg (Director)…
Industry Colleagues
- In the Biotechnology industry, Laura Sepp-Lorenzino has 30,261 colleagues in 2,283 companies located in 40 countries. 14,408 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Laura Sepp-Lorenzino.
Get in Touch
and ask for Laura Sepp-Lorenzino.
